Effect of Intravenous Infusion of Lidocaine on Patients Undergoing Radical Resection of Colorectal Tumors

• Status: Recruiting
• Trial end date: 2023-12-30
• Target enrollment: 0
• Participant gender: All

Summary

Colorectal cancer (CRC) is one of the most common malignant tumors in the world. Surgical resection is the main treatment option for colorectal cancer patients. Surgery may enhance or accelerate tumor recurrence and metastasis. Multiple factors in the tumor microenvironment play important roles in tumor recurrence and metastasis, and modulating the tumor microenvironment can inhibit disease progression. Lidocaine has been found to inhibit tumor growth in animal experiments.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Affiliated Hospital of Nantong University
• Treatments: Anesthetics

Criteria

Inclusion Criteria:

• colorectal tumor patients

Exclusion Criteria:

• Weight <45kg and >100kg

• Sensitivity or hypersensitivity to lidocaine

• Second or third degree heart block

• Severe heart failure (ejection fraction < 20%)

• History of active rhythm disorder

• Acute severe liver and kidney injury

• History of uncontrolled seizures

• History of acute porphyria.